230 related articles for article (PubMed ID: 11589429)
1. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells.
Blümcke I; Becker AJ; Normann S; Hans V; Riederer BM; Krajewski S; Wiestler OD; Reifenberger G
J Neuropathol Exp Neurol; 2001 Oct; 60(10):984-93. PubMed ID: 11589429
[TBL] [Abstract][Full Text] [Related]
2. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors.
Blümcke I; Müller S; Buslei R; Riederer BM; Wiestler OD
Acta Neuropathol; 2004 Aug; 108(2):89-96. PubMed ID: 15146346
[TBL] [Abstract][Full Text] [Related]
3. Neural antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors.
Wolf HK; Buslei R; Blümcke I; Wiestler OD; Pietsch T
Acta Neuropathol; 1997 Nov; 94(5):436-43. PubMed ID: 9386775
[TBL] [Abstract][Full Text] [Related]
4. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
5. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical comparative analysis of GFAP, MAP - 2, NOGO - A, OLIG - 2 and WT - 1 expression in WHO 2016 classified neuroepithelial tumours and their prognostic value.
Schwab DE; Lepski G; Borchers C; Trautmann K; Paulsen F; Schittenhelm J
Pathol Res Pract; 2018 Jan; 214(1):15-24. PubMed ID: 29258767
[TBL] [Abstract][Full Text] [Related]
7. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
8. Differential localization of high- and low-molecular-weight variants of microtubule-associated protein 2 in the developing rat telencephalon.
Fujimori K; Takauji R; Tamamaki N
J Comp Neurol; 2002 Aug; 449(4):330-42. PubMed ID: 12115669
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analyses of neural stem cell lineage markers in normal feline brains and glial tumors.
Yoshida K; Chambers JK; Nibe K; Kagawa Y; Uchida K
Vet Pathol; 2024 Jan; 61(1):46-57. PubMed ID: 37358305
[TBL] [Abstract][Full Text] [Related]
10. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
[TBL] [Abstract][Full Text] [Related]
11. In vitro identification and functional characterization of glial precursor cells in human gliomas.
Colin C; Baeza N; Tong S; Bouvier C; Quilichini B; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):189-202. PubMed ID: 16599947
[TBL] [Abstract][Full Text] [Related]
12. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
[TBL] [Abstract][Full Text] [Related]
13. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas.
Decaestecker C; Lopes BS; Gordower L; Camby I; Cras P; Martin JJ; Kiss R; VandenBerg SR; Salmon I
J Neuropathol Exp Neurol; 1997 Apr; 56(4):391-402. PubMed ID: 9100670
[TBL] [Abstract][Full Text] [Related]
14. Microtubule-Associated Protein 2 Expression in Canine Glioma.
Demeter EA; Frank C; Rissi DR; Porter BF; Miller AD
Front Vet Sci; 2019; 6():395. PubMed ID: 31803765
[TBL] [Abstract][Full Text] [Related]
15. Well-differentiated pediatric glial neoplasms with features of oligodendroglioma, angiocentric glioma and dysembryoplastic neuroepithelial tumors: a morphological diagnostic challenge.
Keser H; Barnes M; Moes G; Lee HS; Tıhan T
Turk Patoloji Derg; 2014; 30(1):23-9. PubMed ID: 24448703
[TBL] [Abstract][Full Text] [Related]
16. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
[TBL] [Abstract][Full Text] [Related]
17. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
18. MAP2 and nestin co-expression in dysembryoplastic neuroepithelial tumors.
Duggal N; Iskander S; Hammond RR
Clin Neuropathol; 2003; 22(2):57-65. PubMed ID: 12670051
[TBL] [Abstract][Full Text] [Related]
19. Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
Capper D; Reuss D; Schittenhelm J; Hartmann C; Bremer J; Sahm F; Harter PN; Jeibmann A; von Deimling A
Acta Neuropathol; 2011 Feb; 121(2):241-52. PubMed ID: 21069360
[TBL] [Abstract][Full Text] [Related]
20. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]